Skip to content
Review Open access

Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration

Sep 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 124 references
Medicine

TL;DR

It is concluded that biomarker-driven precision diagnosis in axSpA requires continued biomarker discovery alongside the construction of shared infrastructure—multi-modal datasets, standardized pipelines, and prospective validation cohorts—to integrate existing and emerging biomarkers into clinically deployable tools.

Abstract

Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease primarily affecting the sacroiliac joints and spine, with an estimated global prevalence of 0.3–1.5%. Despite advances in classification criteria and imaging techniques, diagnostic delay remains a persistent clinical challenge, with patients waiting a median of 2–6 years from symptom onset to confirmed diagnosis. Biomarkers—broadly categorized into clinical, molecular, and imaging modalities—offer the potential to shorten this diagnostic gap by providing objective, quantifiable, and earlier indicators of disease. This narrative review maps the current landscape of biomarkers for the diagnosis of axSpA across all three modalities, with particular attention to how machine learning and multi-omics integration are reshaping the diagnostic paradigm. We examine established clinical markers (HLA-B27, inflammatory back pain criteria, C-reactive protein), survey the molecular biomarker literature spanning genomics, proteomics, metabolomics, and liquid biopsy, and trace the imaging trajectory from conventional radiography and MRI through to radiomics and deep learning models that now approach the performance of expert radiologists. We further explore multimodal fusion—the integration of clinical, molecular, and imaging biomarkers into unified diagnostic models—and identify barriers to clinical translation: the lack of prospective external validation, inconsistent standardization, and unresolved questions about algorithmic fairness across diverse populations. We conclude that biomarker-driven precision diagnosis in axSpA requires continued biomarker discovery alongside the construction of shared infrastructure—multi-modal datasets, standardized pipelines, and prospective validation cohorts—to integrate existing and emerging biomarkers into clinically deployable tools.

Read PDF

Similar papers

Open access Sep 2026

Clinical and MRI features associated with remission following biological therapy in axial spondyloarthritis

To evaluate clinical and MRI features associated with clinical response in patients with axial spondyloarthritis (axSpA) initiating biological therapy. Forty-one biologic-naïve axSpA patients underwent baseline sacroiliac joint MRI before starting biological therapy. Clinical, inflammatory markers, disease activity sco...

A. B. Azuaga, A. García-Diez, Claudia Arango et al. · 0 citations
Open access Oct 2026

Artificial intelligence-based decision support for axial spondyloarthritis integrating inflammatory and structural MRI information

Axial spondyloarthritis (axSpA) assessment on MRI is complicated by interpretation difficulty and by clinical variables that may be incomplete at the time of imaging. We aimed to develop an image-only deep learning framework to approximate the clinical assessment of axSpA from sacroiliac joint (SIJ) MRI, integratin...

Yunseong Kim, Seulkee Lee, Seonyoung Kang et al. · 0 citations
Review Oct 2026

Molecular imaging in adult spondylodiscitis: current evidence, clinical applications, and future perspectives.

Adult spondylodiscitis is an infection of the intervertebral disc and adjacent vertebral bodies that may progress to paravertebral extension, epidural involvement, spinal instability, sepsis, and neurological compromise. Because clinical symptoms and laboratory markers are often nonspecific, imaging is central to diagn...

A. Al-ibraheem, E. Estrada-Lobato, S. Ruzzeh et al. · 0 citations
Review Open access Sep 2026

Imaging-detected tenosynovitis in rheumatoid arthritis: from early diagnosis to disease monitoring

This narrative review provides an updated overview of the pivotal role of imaging-detected tenosynovitis in the diagnosis and management of rheumatoid arthritis (RA). Tenosynovitis emerges as one of the earliest pathological events in inflammatory arthritis, and its histopathological features are indistinguishable fr...

N. P. B. de Andrade, R. M. da Silva Chakr, C. Brenol · 0 citations
Review Open access Sep 2026

Advancing insights into fibromyalgia: an updated review of diagnosis and differential diagnosis

ABSTRACT Introduction Despite advances in understanding nociplastic pain and central sensitization, fibromyalgia remains a challenging clinical diagnosis due to the absence of specific biomarkers, extensive symptom overlap with other conditions, and persistent misconceptions about its pathophysiology. Areas covered Thi...

V. Segura-Jiménez · 0 citations
Open access Oct 2026

Blood biomarkers identified with multi-omics combined with clinical and muscle imaging in oculopharyngeal muscular dystrophy

Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset, slowly progressive muscular dystrophy characterized by dysphagia, eyelid ptosis, and proximal limb weakness. Clinical trial readiness in OPMD requires development of sensitive indicators of disease progression and potential response to therapies in de...

I. Smith, Matthew Triolo, Karim Karimi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.